A review of sevoflurane induction methods in Childre
Not Applicable
Completed
- Conditions
- Health Condition 1: null- ASA I and ASA II patients
- Registration Number
- CTRI/2017/12/010773
- Lead Sponsor
- Ameya Ghude
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
1. ASA-I and II
2. Either sex
3. Age group 6 months to 8 years
4. Patients undergoing general anaesthesia with
supraglottic device
5. duration of surgery from 20 minutes to 90
minutes
Exclusion Criteria
1. Age group < 6 months and >8 years
2. ASA III and above
3. Non-starved patients
4. Difficult airway
5. Active upper or lower respiratory tract
infection
6. Craniofacial abnormalities
7. Cardiopulmonary defects
8. Hepatic or renal insufficiency
9. Known seizure disorder
10. Neuromuscular defects
11. Bleeding/clotting abnormality
12. Non-consenting parent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Induction time by the two <br/ ><br> induction methods <br/ ><br>2. Amount of Sevoflurane used <br/ ><br> by the two induction <br/ ><br> methods <br/ ><br>3. Side effects of the two <br/ ><br> induction methodsTimepoint: 1. At the time of loss of <br/ ><br> eyelash reflex. <br/ ><br>2. At the time of successful <br/ ><br> I gel insertion. <br/ ><br>3. 2 minutes after successful <br/ ><br> I gel insertion
- Secondary Outcome Measures
Name Time Method MAC achieved during the two <br/ ><br> induction methodsTimepoint: 1. At the time of loss of <br/ ><br> eyelash reflex. <br/ ><br>2. At the time of successful <br/ ><br> I gel insertion. <br/ ><br>3. 2 minutes after successful <br/ ><br> I gel insertion